Literature DB >> 23480298

Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific (1rs8418532).

Bing Du1, Shengmao Liu, Chengji Cui, Songyan Wang, Wenpeng Cui.   

Abstract

BACKGROUND: So far, studies on the association between the glucose transporter 1 (GLUT1) rs841853 polymorphism and type 2 diabetes mellitus (T2DM) risk have generated considerable controversy. The present study was performed to clarify the association of this genetic variation with T2DM.
METHODS: A comprehensive literature search of electronic databases was conducted to obtain articles focused on the relationship between the GLUT1 rs841853 polymorphism and T2DM, followed by a systemic meta-analysis.
RESULTS: Fourteen articles and 19 individual studies were included for analysis. Main analyses revealed extreme heterogeneity and random effect pooled odds ratios (OR) were weakly significant in allele contrast (OR 1.28; 95% confidence interval [CI] 1.01, 1.63; P=0.04) and dominant model (OR 1.52; 95% CI 1.19, 1.94; P=0.0008) for T allele. Subgroup analyses for Caucasians showed marginal positive results in the dominant model. However, analyses for Asians yielded an obvious relationship to T2DM risk in all genetic models. Interestingly, T allele even seemed to be a protective factor against the development of T2DM in Blacks in allele contrast. Sensitivity analyses did not alter materially for most comparisons and no publication bias was found in this meta-analysis.
CONCLUSIONS: The results of the present meta-analysis provide evidence that the GLUT1 rs841853 polymorphism may confer increased susceptibility to T2DM in Asians. However, there is no currently available strong evidence supporting the association between this genetic variation and T2DM in Caucasians, Blacks, or the overall population.
© 2013 Wiley Publishing Asia Pty Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine.

Entities:  

Keywords:  gene polymorphism; glucose transporter 1; meta-analysis; rs841853; type 2 diabetes mellitus; 基因多态性, 对葡萄糖转移酶1,Meta分析,rs841853,2型糖尿病

Mesh:

Substances:

Year:  2013        PMID: 23480298     DOI: 10.1111/1753-0407.12042

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  6 in total

1.  Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity.

Authors:  Juan Chen; Lin Wu; Ying Wang; Jiye Yin; Xiangping Li; Zhan Wang; Huihua Li; Ting Zou; Chenyue Qian; Chuntian Li; Wei Zhang; Honghao Zhou; Zhaoqian Liu
Journal:  Tumour Biol       Date:  2015-09-11

2.  Is rs759853 polymorphism in promoter of aldose reductase gene a risk factor for diabetic nephropathy? A meta-analysis.

Authors:  Wenpeng Cui; Bing Du; Yingchun Cui; Lili Kong; Hao Wu; Yangwei Wang; Lining Miao; Wenhua Zhou
Journal:  Eur J Med Res       Date:  2015-02-10       Impact factor: 2.175

3.  Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients.

Authors:  Azhar Mohamed Nomair; Mona Mohamed Kamal ElDeeb; Dalia Aly Maharem
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

4.  Interaction between a diabetes-related methylation site (TXNIP cg19693031) and variant (GLUT1 rs841853) on fasting blood glucose levels among non-diabetics.

Authors:  Hao-Hung Tsai; Chao-Yu Shen; Chien-Chang Ho; Shu-Yi Hsu; Disline Manli Tantoh; Oswald Ndi Nfor; Shin-Lin Chiu; Ying-Hsiang Chou; Yung-Po Liaw
Journal:  J Transl Med       Date:  2022-02-14       Impact factor: 5.531

5.  The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.

Authors:  I Stefanidis; M Tziastoudi; E E Tsironi; E Dardiotis; S V Tachmitzi; A Fotiadou; G Pissas; K Kytoudis; M Sounidaki; G Ampatzis; P R Mertens; V Liakopoulos; T Eleftheriadis; G M Hadjigeorgiou; M Santos; E Zintzaras
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

6.  Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates.

Authors:  Sarah ElHajj Chehadeh; Noura S Sayed; Hanin S Abdelsamad; Wael Almahmeed; Ahsan H Khandoker; Herbert F Jelinek; Habiba S Alsafar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-06       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.